Clinical Trial Update: Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy Drug [Phase 2, Phase 3]

View source ↗

Summary

This document notes an ongoing Phase 2/Phase 3 clinical trial evaluating the safety and efficacy of a gene therapy for Hemophilia B, sponsored by Shanghai Xinzh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Snippet

Sponsor: Shanghai Xinzhi BioMed Co., Ltd. | Conditions: Hemophilia B | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING